Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to Date is a research paper published in OncoTargets and Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R21 AG070502
National Institutes of Health
Grant: 1R21AG070502-01
Screening to Improve Survival in AL Amyloidosis
Fields of Study
Keywords
Sustainable Development Goals